KPC PHARMACEUTICALS, INC. — Investor Relations & Filings
About KPC PHARMACEUTICALS, INC.
KPC Pharmaceuticals, Inc. specializes in the research, development, and manufacturing of pharmaceutical products, with a significant focus on natural and botanical medicines. The company is a global leader in the production of artemisinin-based anti-malarial treatments, including artemether and its derivatives. Its portfolio encompasses a wide range of therapeutic areas, notably cardiovascular and cerebrovascular health, where it utilizes Panax notoginseng saponins as a core component. KPC integrates traditional medicinal knowledge with modern pharmacological techniques to develop standardized botanical extracts and chemical drugs. The organization operates extensive production facilities and research centers dedicated to drug discovery and quality control. Its business activities extend to the distribution of healthcare products and the provision of medical services, aiming to provide comprehensive health solutions through innovation in natural medicine and biotechnology.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 昆药集团关于会计政策变更的公告 | 2026-04-24 | Chinese | |
| 昆药集团十一届十八次董事会决议公告 | 2026-04-24 | Chinese | |
| 昆药集团关于部分董事及高级管理人员变更的公告 | 2026-04-24 | Chinese | |
| 昆药集团2026年第一季度报告 | 2026-04-24 | Chinese | |
| 昆药集团关于召开2025年度暨2026年第一季度业绩说明会的公告 | 2026-04-24 | Chinese | |
| 昆药集团关于获得药品注册证书的公告 | 2026-04-20 | Chinese |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 40930674 | 昆药集团关于会计政策变更的公告 | 2026-04-24 | Chinese | ||
| 40930670 | 昆药集团十一届十八次董事会决议公告 | 2026-04-24 | Chinese | ||
| 40930667 | 昆药集团关于部分董事及高级管理人员变更的公告 | 2026-04-24 | Chinese | ||
| 40930663 | 昆药集团2026年第一季度报告 | 2026-04-24 | Chinese | ||
| 40930660 | 昆药集团关于召开2025年度暨2026年第一季度业绩说明会的公告 | 2026-04-24 | Chinese | ||
| 40930658 | 昆药集团关于获得药品注册证书的公告 | 2026-04-20 | Chinese | ||
| 34821594 | 北京德恒（昆明）律师事务所关于昆药集团股份有限公司2026年第一次临时股东会的法律意见 | 2026-04-17 | Chinese | ||
| 34821589 | 昆药集团2026年第一次临时股东会决议公告 | 2026-04-17 | Chinese | ||
| 40930656 | 昆药集团2026年第一次临时股东会会议资料 | 2026-04-10 | Chinese | ||
| 40930654 | 昆药集团关于高级管理人员变更的公告 | 2026-03-31 | Chinese | ||
| 40930651 | 昆药集团关于控股股东的间接控股股东华润医药集团有限公司刊发2025年业绩公告的提示性公告 | 2026-03-25 | Chinese | ||
| 40930646 | 昆药集团关于2026年度融资额度的公告 | 2026-03-23 | Chinese | ||
| 40930637 | 昆药集团十一届十六次董事会决议公告 | 2026-03-23 | Chinese | ||
| 40930623 | 昆药集团关于2026年度担保计划的公告 | 2026-03-23 | Chinese | ||
| 40930612 | 昆药集团关于召开2026年第一次临时股东会的通知 | 2026-03-23 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Aclaris Therapeutics, Inc.
Clinical-stage biopharmaceutical company developing drugs f…
|
ACRS | US | Manufacturing |
|
Acrivon Therapeutics, Inc.
Clinical-stage biopharma using proteomics to develop precis…
|
ACRV | US | Manufacturing |
|
ACRUX LIMITED
Develops and commercializes topical and transdermal drug de…
|
ACR | AU | Manufacturing |
|
Acticor Biotech
Develops treatments for thrombotic diseases, focusing on ac…
|
ALACT | FR | Manufacturing |
|
Actinium Pharmaceuticals, Inc.
Clinical-stage company developing targeted radiotherapies f…
|
ATNM | US | Manufacturing |
|
ACTUATE THERAPEUTICS, INC.
Clinical-stage biopharma developing therapies for cancers w…
|
ACTU | US | Manufacturing |
|
AcuCort AB
Develops user-friendly drug formulations for severe and acu…
|
ACUC | SE | Manufacturing |
|
Acumen Pharmaceuticals, Inc.
Clinical-stage biopharma developing targeted therapies for …
|
ABOS | US | Manufacturing |
|
Acurx Pharmaceuticals, Inc.
Clinical-stage biopharma developing a new class of antibiot…
|
ACXP | US | Manufacturing |
|
Adaptimmune Therapeutics PLC
Commercial-stage biopharma developing TCR T-cell therapies …
|
ADAP | GB | Manufacturing |
KPC PHARMACEUTICALS, INC. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/56720/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=56720 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=56720 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=56720 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 56720}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for KPC PHARMACEUTICALS, INC. (id: 56720)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.